Milestone Scientific Inc.MLSSNYSE
LOADING
|||
Switch Symbol:
R&D Expense Growth Recovery in Progress
Trending higher, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
-68.67%
↓ 143% below average
Average (39q)
159.90%
Historical baseline
Range
High:1898.73%
Low:-95.67%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | -68.67% |
| Q2 2025 | -85.97% |
| Q1 2025 | 69.69% |
| Q4 2024 | -6.26% |
| Q3 2024 | -26.32% |
| Q2 2024 | 234.32% |
| Q1 2024 | -46.75% |
| Q4 2023 | 3.77% |
| Q3 2023 | -20.21% |
| Q2 2023 | 52.23% |
| Q1 2023 | -44.52% |
| Q4 2022 | 52.23% |
| Q3 2022 | -37.65% |
| Q2 2022 | -42.61% |
| Q1 2022 | 60.07% |
| Q4 2021 | -18.53% |
| Q3 2021 | 65.34% |
| Q2 2021 | 1210.02% |
| Q1 2021 | -76.76% |
| Q4 2020 | 230.07% |
| Q3 2020 | -80.18% |
| Q2 2020 | 0.64% |
| Q1 2020 | 34.17% |
| Q4 2019 | 908.92% |
| Q3 2019 | -91.69% |
| Q2 2019 | 1405.34% |
| Q1 2019 | -78.83% |
| Q4 2018 | 1898.73% |
| Q3 2018 | -84.65% |
| Q2 2018 | -95.67% |
| Q1 2018 | 633.60% |
| Q4 2017 | 82.31% |
| Q3 2017 | -85.94% |
| Q2 2017 | 14.33% |
| Q1 2017 | -79.59% |
| Q4 2016 | 69.63% |
| Q3 2016 | -1.96% |
| Q2 2016 | 115.65% |
| Q1 2016 | 179.94% |
| Q4 2015 | 147.82% |